Goldman Sachs Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $26

Olema Pharmaceuticals, Inc. +2.83% Post

Olema Pharmaceuticals, Inc.

OLMA

27.98

27.98

+2.83%

0.00% Post
Goldman Sachs analyst Richard Law maintains Olema Pharmaceuticals (NASDAQ: OLMA) with a Buy and raises the price target from $18 to $26.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via